Mindfulness-based cancer recovery and Tai Chi/Qigong improve fatigue and pain interference in cancer survivorsTai Chi and mindfulness help cancer survivors manage pain and fatigue

This randomized, patient-preference comparative effectiveness trial evaluated the impact of two distinct mind-body interventions on the quality of life for a population of 587 distressed cancer survivors. The study aimed to compare Mindfulness-based cancer recovery (MBCR) and Tai Chi/Qigong (TCQ) against a waitlist control group to determine their efficacy in managing common symptoms associated with cancer survivorship.

The study utilized a partially randomized design where patients could choose their preferred intervention. The intervention groups consisted of those practicing MBCR and those practicing TCQ, while the control group remained on a waitlist. The specific dosing, duration, and frequency of the MBCR and TCQ protocols were not reported.

Regarding the primary outcome, specific data for the primary endpoint were not reported. However, significant improvements were observed across several key secondary outcomes. For sleep quality, the TCQ group demonstrated an average improvement of 1.9 points compared with waitlist controls (p =.004). This indicates a statistically significant benefit for sleep specifically in the TCQ cohort.

Fatigue and pain interference also showed statistically significant improvements in both intervention groups compared to the waitlist. For fatigue, the MBCR group showed an improvement of 3.66 points (p =.036), and the TCQ group showed an improvement of 3.42 points (p =.043). Regarding pain interference, both the MBCR and TCQ groups showed over 1 point of change compared to waitlist controls, with p-values of.029 and.002, respectively.

Safety and tolerability data were not reported for this study. There were no reported adverse events, serious adverse events, or discontinuations provided in the data. Consequently, the tolerability of both MBCR and TCQ for this specific population cannot be quantified from the available evidence.

While the study provides evidence for the efficacy of these interventions, it is limited by the fact that it is a partially randomized, patient-preference trial. This design can introduce selection bias, as patients choosing one intervention over another may differ in baseline characteristics or motivation. Furthermore, the lack of reported duration and specific dosing for the interventions makes it difficult to determine the minimum effective dose for clinical application.

These results suggest that both MBCR and TCQ are viable options for managing fatigue and pain in cancer survivors. Specifically, TCQ may be a preferred option for patients whose primary concern is sleep quality, as it was the only intervention shown to improve sleep in this study. The correlation between sleep, fatigue, and pain interference was reported as mild to moderate.

Clinical implications suggest that clinicians can offer both MBCR and TCQ as evidence-based options for improving fatigue and pain in survivors. However, the choice between the two may depend on the specific symptoms the patient prioritizes, such as sleep. Questions remain regarding the optimal duration of these programs and the specific components of the protocols that drive the observed improvements.